NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,245 | -2.6% | 2,520 | 0.0% | 0.00% | – |
Q2 2023 | $18,724 | +7.2% | 2,520 | 0.0% | 0.00% | – |
Q1 2023 | $17,464 | -32.6% | 2,520 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $25,906 | -43.7% | 2,520 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $46,000 | -41.0% | 2,520 | +65.8% | 0.00% | -50.0% |
Q2 2022 | $78,000 | -86.6% | 1,520 | -80.7% | 0.00% | -80.0% |
Q1 2022 | $581,000 | -55.7% | 7,882 | -14.1% | 0.01% | -52.4% |
Q4 2021 | $1,311,000 | +182.5% | 9,171 | +310.3% | 0.02% | +133.3% |
Q3 2021 | $464,000 | +24.4% | 2,235 | +27.3% | 0.01% | +12.5% |
Q2 2021 | $373,000 | -3.4% | 1,756 | -17.6% | 0.01% | -20.0% |
Q1 2021 | $386,000 | +532.8% | 2,130 | +287.3% | 0.01% | +400.0% |
Q4 2020 | $61,000 | +1120.0% | 550 | +1000.0% | 0.00% | – |
Q3 2020 | $5,000 | +25.0% | 50 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | -96.0% | 50 | -99.3% | 0.00% | -100.0% |
Q1 2020 | $101,000 | – | 7,418 | +14736.0% | 0.01% | – |
Q4 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $18,549,000 | 4.18% |
OPTIMAS CAPITAL Ltd | 27,800 | $2,047,000 | 1.92% |
RA Capital Management | 692,794 | $51,024,000 | 1.11% |
Mendel Capital Management LLC | 13,689 | $1,008,000 | 0.95% |
Rock Springs Capital Management LP | 448,200 | $33,010,000 | 0.83% |
SECTORAL ASSET MANAGEMENT INC | 50,500 | $3,719,000 | 0.66% |
TOBAM | 173,685 | $12,792,000 | 0.64% |
SECTOR GAMMA AS | 38,324 | $2,823,000 | 0.61% |
HAP Trading, LLC | 212,100 | $12,723,000 | 0.53% |
Parametrica Management Ltd | 9,539 | $703,000 | 0.52% |